Vivione Biosciences Inc. (TSXV:VBI) announced a brokered private placement on best efforts basis of up to 28,571,429 common shares at a price of CAD 0.35 per common share for gross proceeds of up to CAD 10,000,000 on January 28, 2015. The completion of the transaction is subject to negotiation of final terms of the transaction with one or more investors and the receipt of all necessary regulatory approvals, including the conditional approval of the Exchange. The transaction is anticipated to close in April, 2015.

The common shares issued will be subject to a four month restriction on resales under applicable Canadian securities laws.